Membrane proteinase 3 expression and ANCA-induced neutrophil activation.
their target antigens on cytokine-primed neutrophils and on monocytes activating intracellular signal transduction pathways, such as PI3-K/Akt [3] [4] [5] [6] . ANCA-activated neutrophils and monocytes generate reactive oxygen species (ROS), release toxic granule components, and upregulate surface adhesion molecules, ultimately causing vascular damage [7] [8] [9] [10] [11] [12] . Recently, the pathogenic role of ANCA was elegantly demonstrated in an animal model [13] . The major target antigen in WG is PR3. This serine protease is localized in azurophilic (primary) and specific (secondary) granules, and in secretory vesicles [14] [15] [16] . In addition to an intracellular pool, PR3 can be detected on the surface of isolated resting neutrophils [16, 17] . Membrane PR3 (mPR3) expression is bimodal. Within a given donor an mPR3 high and mPR3 low subset neutrophil population can be distinguished [18, 19] . We found recently that the mPR3 phenotype is under strong genetic influences [20] . A large percentage of mPR3 high neutrophils provides a risk factor for vasculitis and is associated with relapse [19] [20] [21] . Possibly, neutrophils with high mPR3 expression can more easily interact with PR3-ANCA, resulting in stronger activation. We investigated whether or not the mPR3 phenotype affects ANCA-induced respiratory burst, intracellular signaling, and release of granule proteins. Because additional surface molecules, including b2-integrins and Fcc receptors IIa and IIIb, were reported to be important for neutrophil activation by ANCA, we also studied the expression of these molecules in the mPR3 high and mPR3 low neutrophil subsets. Finally, mPR3 is enzymatically active and is resistant to the naturally occurring inhibitors alpha1-antitrypsin and elafin [22] . Because PR3 degrades extracellular matrix components such as fibronectin [22] [23] [24] , we examined the possibility that high mPR3 expression favors chemotactic migration.
METHODS

Materials
Recombinant tumor necrosis factor (TNF)-a was obtained from Genzyme (Rüsselsheim, FRG). The monoclonal mouse antibody to PR3 was obtained from CLB (Amsterdam, The Netherlands), and fluoroscein isothiocyanate (FITC)-conjugated F(ab)2-fragment of goat antimouse immunoglobulin (Ig)G was from Dako (Hamburg, FRG). Dextran was purchased from Amersham Pharmacia (Amsterdam, The Netherlands). Hank's balanced salt solution (HBSS), phosphate-buffered saline (PBS), and Trypan blue were from Seromed (Berlin, FRG). Endotoxin-free reagents and plastic disposables were used in all experiments. Histopaque 1083 was obtained from Sigma-Aldrich (Deisenhofen, FRG). The following antibodies were used: from Immunotech (Krefeld, FRG), CD11a (FITC), CD11b (FITC), CD11c (PE), and CD18 (FITC). CD16 and CD35 (FITC) were from Cymbus Biotech (Hants, UK), and CD32 (FITC) from Dako. CD63 (PE) was from CLB.
Isolation of human neutrophils
Neutrophils from healthy volunteers were isolated from heparinized whole blood by red blood cell sedimentation with dextran 1%, followed by Ficoll-Hypaque density gradient centrifugation, and hypotonic erythrocyte lysis. Neutrophils were centrifuged (10 minutes at 1050 rpm) and resuspended in HBSS with calcium and magnesium (HBSS ++ ). The cell viability was detected in every cell preparation by Trypan blue exclusion and exceeded 99%. The neutrophil percentage in the suspension was >95% by Wright-Giemsa staining.
Preparation of immunoglobulins
Human immunoglobulin G (IgG) was prepared from patients with biopsy-proven WG (two PR3-ANCA) and microscopic polyangiitis (two MPO-ANCA) as well as from two healthy control subjects as described [25] .
Separation of mPR3
high and mPR3 low neutrophils by magnetic beads mPR3 high and mPR3 low neutrophils were separated with magnetic cell sorting (MACS) separation columns (Miltenyi Biotec, Bergisch Gladbach, Germany) as described in the manufacturer's manual. All steps were carried out on ice. Freshly isolated neutrophils were stained with a monoclonal antibody (mab) to PR3 (CLB 12.8,IgG1j). MACS rat antimouse IgG1 were added, and cells were pipetted onto a MACS LD Column (Miltenyi Biotech). The flow-through containing the nonlabeled mPR3 low neutrophils was collected. Columns were removed from the magnet and labeled mPR3 high neutrophils were collected. The cell 99% viability was detected in every cell preparation by Trypan blue exclusion.
Assessment of neutrophil adhesion
Well plates (96-well) coated with (10 lg/cm 2 ) fibronectin were used for the adhesion assay. Polymorphonuclear cells (PMN) (1 × 10 5 ) in 100 lL HBSS ++ were either left untreated or were treated with 2 ng/mL TNF-a. Plates were incubated at 37
• C in 5% CO 2 for the indicated time period. Wells were flicked dry, washed three times with PBS, and adherent cells were estimated using the MPO assay. Briefly, adherent cells were lysed in 100 lL of 0.5% Triton-X-100 for 10 minutes. Substrate (100 lL; 2.2'-Azino-bis (3-Ethylbenzthiazoline-6-sulfonicacid; Sigma, Deisenhofen, FRG) was added and optical density (OD) was read after 10 minutes at 450 nm with a microtiter plate reader. OD of the experimental sample was compared with a standard curve that showed an excellent correlation between OD and cell number (R 2 = 0.96).
Superoxide generation assay
Superoxide was measured using the assay of SODinhibitable reduction of ferricytochrome C as described by Pick and Mizel [26] . Neutrophils were pretreated with 5 lg/mL cytochalasin B for 15 minutes. Cells (0.75 × 10 6 ) were primed with 2 ng/mL TNF-a for 15 minutes before human ANCA preparations were added. No priming was performed for phorbol 12-myristate 13-acetate (PMA) or N-formyl-methionyl-leucyl-phenyalanine (fMLP) stimulation. The final concentrations were 125 lg/mL for purified IgG preparations, 25 ng/mL for PMA, and 10 −6 mol/L for fMLP. Experiments were done in duplicate. Samples were incubated in 96-well plates at 37
• C for up to 60 minutes, and the absorption of samples with and without 300 U/mL SOD was scanned repetitively at 550 nm using a Microplate Autoreader (Molecular Devices, Munich, Germany). The final ferricytochrome C concentration was 50 lmol/L, and the final cell concentration was 3.75 × 10 6 /mL.
Degranulation assay
Freshly isolated neutrophils (5 × 10 5 ) were preincubated with 5 lg/mL cytochalasin B and primed in a 96-well microtiter plate for 15 minutes with 2ng/mL TNF-a. Stimulation was performed with PR3-ANCA or MPO-ANCA or human control IgG or fMLP 10 −6 mol/L for up to 120 minutes. At 30-minute intervals the cell-free supernatants were collected by centrifugation (7 min, 250g), and b-glucuronidase activity was assessed by the cleavage of phenolphtaleinglucuronic acid (Sigma-Aldrich). Each tube contained 50 lL of a 0.01 mol/L solution phenolphtalein-glucuronic acid in 0.1 mol/L acetic buffer, pH 4.6, with 0.04% Triton X-100, and was mixed with 50 lL of the cell-free supernatant. After a 14-hour incubation in the dark at 37
• C, the reaction was stopped by adding 1 mL of a 0.02 mol/L solution of glycine buffer, pH 10.4 . OD values were measured at 405 nm. Nonstimulated neutrophils served as baseline, whereas the total neutrophil b-glucuronidase content was obtained by incubation 5 × 10 5 neutrophils with 1% Triton X-100.
Determination of surface antigen expression by flow cytometry
Fluorescence-activated cell sorting (FACS) was used as described previously to evaluate the PR3 expression on neutrophils [25] . For double labeling, cells were incubated after stimulation with conjugated antibodies against CD11a, CD11b, CD11c, CD16, CD32, CD35, and CD63. Flow cytometry was performed using a FACSort (Becton Dickinson, Heidelberg, FRG), and 10,000 events per sample were collected.
Transmigration assay
The ability of neutrophils to migrate through extracellular matrix components was tested with 20 lg/mL fibronectin-coated transwells (3.0 lm, 6.5 mm from Corning, NY, USA). Neutrophils (1.5 × 10 6 ) in HBSS ++ were stimulated at 37
• C with 50 ng/mL interleukin-8 to transmigrate to the lower well. For time-course studies, the upper chamber of the transwell device was gently moved to a new well in 30-minute intervals. Transmigrated cells were quantified by MPO assay as described previously [27] , and are given as the percentage of neutrophils that migrated from the apical to the basal aspect of the insert membranes. Calculation was done as follows: percentage migration = (MPO − activity of basal fluid/MPO activity of the neutrophil suspension added to apical aspect) × 100. When indicated, transmigrated neutrophils were stained for surface PR3 and analyzed by FACS.
Western blot analysis for phosphorylated Akt and ERK
Neutrophils were incubated after separation of mPR3 high and mPR3 low at a concentration of 2 × 10 6 /mL in the presence of buffer control or with the indicated stimuli. Western blotting was performed as previously described using phosphospecific antibodies [5] . Densitometry was performed with scanned x-ray films and the NIH image program.
Statistical analysis
Results are given as mean ± SEM. Comparisons were made by t test or analysis of variance (ANOVA) as appropriate.
RESULTS
ANCA-induced superoxide generation in mPR3 high
and mPR3 low neutrophils
We tested the hypothesis that low and high mPR3 neutrophils differ in the magnitude of PR3-ANCA-induced activation. To exclude interaction between both subsets, we physically separated mPR3 high and mPR3 low neutrophils by magnetic cell sorting. We yielded two populations of cells with >90% of mPR3 high and >90% mPR3 low , respectively ( Fig. 1A-C ). After sorting, neutrophils were primed with TNF-a and subsequently activated with PR3-ANCA, MPO-ANCA, control immunoglobulins, respectively, or unprimed cells were stimulated with PMA. Stimulation of mPR3 high neutrophils (Fig. 2 ) resulted in significantly higher amounts of superoxide generation, compared to mPR3 low cells (33.7 ± 15.2 nmol O 2 − /10 5 neutrophils vs. 14.6 ± 8.4, P < 0.001, N = 5). In contrast, no difference in the response to human control immunoglobulins, MPO-ANCA, or PMA was observed. We performed experiments to ensure that the sorting algorithm did not influence neutrophil responsiveness, and that the separated mPR3 low and mPR3 high subgroups were not characterized by different activation status. We preincubated neutrophils with buffer control, mab to PR3, and mab to PR3 together with beads, respectively. After this preincubation samples were either challenged with TNF-a/human PR3-ANCA or with buffer control for 45 minutes. Superoxide generation was similar in the three preincubation groups after stimulation with TNF-a/human PR3-ANCA. The results were 16.5 ± 0.7 nmol/0.75 × 10 6 cells/45 minutes in the buffer preincubation group versus 14.0 ± 0.2 nmol in samples preincubated with mab to PR3 alone, and 14.5 ± 2.2 nmol in samples with the mab to PR3 together with beads. In contrast, buffer control did not result in superoxide generation in any of the three preincubation groups. The results were 2.9 ± 1.4 nmol/0.75 × 10 6 cells/45 minutes in the buffer preincubation group versus 1.5 ± 2.2 nmol in samples preincubated with mab to PR3 alone, and 2.5 ± 2.1 nmol in samples with the mab to PR3 together with beads. In addition, our results from Western blot experiments indicate that the sorting procedure did not affect basal or TNF-a-induced phosphorylation of extracellular signal-regulated kinase (ERK) (Fig. 1D ). ERK is a sensitive indicator of neutrophil activation. We have shown previously that ERK controls neutrophil priming [25] . Together, these experiments exclude the possibility that the sorting technique used in this study affected neutrophil responsiveness. These data also provide evidence that mPR3 high neutrophils do not represent a more activated subgroup of cells. When we assessed the percentage of mPR3 high cells in isolated neutrophils aged over 24 hours in culture, we observed no change in this percentage in two independent experiments (0 h: 64% ± 16.9 mPR3 high neutrophils; 2 h: 65% ± 16.3; 4 h: 65% ± 16.3; 8 h: 65% ± 16.9; 12 h: 66% ± 16.3; 24 h: 67% ± 18.4). These experiments exclude both age and activation status as important factors affecting the percentage of mPR3 expression. Next, we titrated a dose response curve using neutrophils from a given individual. We chose this approach because interindividual comparisons are of limited help in neutrophil investigations because of the large degree of variation between different donors. Neutrophils were isolated, and the mPR3 high and mPR3 low subset were separated and remixed to achieve defined samples containing less than 10%, approximately 25%, 50%, 75%, and >90% mPR3 high cells. Samples were primed with TNF-a, stimulated with PR3-ANCA, and superoxide generation was assayed. We observed a superoxide response that increased dose dependently with increasing the percentage of mPR3 high -neutrophils (Fig. 3) . A progressive increase in burst activity occurred from <10% up to 75% mPR3
high -cells and a plateau thereafter.
Phosphylation of Akt in mPR3
high and mPR3 low neutrophils
We studied whether or not the differences in superoxide generation after PR3-ANCA stimulation of mPR3 high and mPR3 low neutrophils were related to differences in PI3-K/Akt activation. After separation of both mPR3 subsets, samples were primed with TNF-a for 15 minutes and stimulated with PR3-ANCA, MPO-ANCA, or human control immunoglobulins for another 15 minutes. We had previously observed that TNF-a-induced Akt phosphorylation peaked after 10 minutes, declining thereafter, and that ANCA resulted in a second phosphorylation peak [5] . The simulation with control immunoglobulins induced very little Akt phosphorylation (Fig. 4) , whereas PR3-ANCA and MPO-ANCA resulted in a significant activation of Akt. However, Akt phosphorylation was significantly higher in PR3-ANCA-stimulated mPR3 high neutrophils compared with the mPR3 low subset. In contrast, no difference was observed after stimulation with MPO-ANCA. Corresponding optical density (OD) measures are given in Figure 4B .
Degranulation in mPR3
high and mPR3 low neutrophils ANCA were shown to stimulate neutrophil degranulation. Thus, we explored whether or not PR3-ANCAinduced release of granule proteins was higher in the mPR3 high subset compared to the PR3 low cells. After separation of both populations, TNF-a-primed samples were challenged with human PR3-ANCA, MPO-ANCA, and human control immunoglobulins, respectively. Because PMA did not trigger degranulation (data not shown), we used fMLP as an additional stimulus in this assay (Fig. 5) . We found significant higher degranulation after stimulation with PR3-ANCA (29% ± 5 of total cellular b-glucuronidase vs. 22% ± 3, P < 0.05, N = 4). In contrast, no difference was observed after stimulation with human control immunoglobulins, MPO-ANCA, or fMLP.
b2-integrin, FccRIIa, and FccRIIIb expression on mPR3 high and mPR3 low neutrophils
We investigated the expression of b2-integrins, FccRIIa, and FccRIIIb because these receptors were implicated in ANCA-induced neutrophil activation. We used double staining and flow cytometry to assess these molecules in both mPR3 high and mPR3 low subsets. The experiments were performed in unstimulated cells, in TNF-a-primed cells, in TNF-a-primed cells challenged with a mab to MPO or to PR3, or with fMLP, respectively. First, the b2-integrins were analyzed. We observed no difference in CD11a (LFA-1), CD11b (Mac-1; CR3), CD11c (p150,95; CR4), or CD18 expressions in resting mPR3 high and mPR3 high neutrophils (Fig. 6) . We confirmed the increase in the amount of membrane-expressed CD11b, CD11c, and CD18 after incubating with the aforementioned activators, whereas CD11a was not up-regulated upon stimulation. However, we found that the up-regulation of these integrin molecules was similar in PR3 high and PR3 low cells (Table 1) .
In addition to studying the expression of adhesion molecules, we assessed the ability of mPR3 low and mPR3 high neutrophils to adhere to extracellular ma- Fig. 3 . Dose-response curve for the effect of mPR3 expression on superoxide production of PR3-ANCA-treated neutrophils. Neutrophils from a given donor were separated into mPR3 high and mPR3 low cells by magnetic sorting and remixed after separation to achieve samples with exactly defined percentages of mPR3 high neutrophils as indicated. After TNF-a priming, cells were incubated with 125 lg/mL PR3-ANCA (N = 2 with 2 different PR3-ANCA preparations). Superoxide was measured with the ferricytochrome assay, and data from the 45-minute time point are depicted. These experiments demonstrate that the PR3-ANCAinduced respiratory burst increased dose dependently with increasing the percentage of mPR3 high neutrophils. trix proteins. mPR3 low and mPR3 high neutrophils were separated by magnetic cell sorting and incubated on a fibronectin-coated surface in the absence and presence of 2 ng/mL TNF-a. Cells were harvested after 60 minutes, and adhesion was determined using the MPO-assay. We observed similar adhesion of mPR3 low and mPR3 high neutrophils after incubation in buffer control (3.4 ± 0.9 × 10 4 and 4.0 ± 1.3 × 10 4 neutrophils, respectively). Furthermore, both populations showed a similar increase in adherence after stimulation with TNF-a (7.0 ± 0.5 × 10 4 and 7.9 ± 1.3 × 10 4 , respectively, N = 2). We then investigated the expression pattern of the Fccreceptor IIA (CD32) and FccIIIb (CD16), which were also reported to play a role in neutrophil activation by ANCA. The expression of both receptors was similar in mPR3 high and mPR3 low resting neutrophils (Fig. 7) . Again, this finding did not change when cells were stimulated ( Table 1) . Because of the necessary fluorescence compensation for double-staining experiments comparisons between the stimuli are difficult. Our aim is merely a comparison between both mPR3 high and mPR3 low neutrophils for a given activator. Taken together, our experiments did not detect additional differentially expressed The data represent membrane expression for the indicated molecules after stimulation with TNF-a, TNF-a + monoclonal anti-PR3, TNF-a + monoclonal anti-MPO, and fMLP, respectively, compared to unstimulated neutrophils (mean percentage ± SEM). molecules in the low and high mPR3 subsets of neutrophils.
Mobilization of azurophilic, specific, and secretory granules in mPR3 high and mPR3 low neutrophils
CD11b is mobilized from specific granules und our data have demonstrated no difference in the mobilization of these granule types. We therefore investigated degranulation of azurophilic granules (CD63) and secretory vesicles (CD35) to study if differences in mPR3 expression resulted from a more general difference in the ability to mobilize intracellular storages that contain PR3. However, we found similar expression of CD35 in resting mPR3 high and mPR3 low neutrophils as well as after stimulation ( Fig. 8 and Table 1 ). CD63 increased only after the stimulation with fMLP, but not when cells were challenged with TNF-a, the mab to PR3, or the mab to MPO (data not shown). However, no difference in CD63 expression with respect to mPR3 subset was observed. These experiments do not support the contention that mPR3 high and mPR3 low subsets result from differences in the ability to mobilize granules or vesicles. Additional flow cytometry experiments were performed to assess the membrane expression pattern of other serine proteinases and MPO as another ANCA antigen. Our results indicate that only PR3, but not elastase, cathepsin G, or MPO, was characterized by a bimodal membrane distribution (Fig. 9) . Transmigration of separated neutrophils and surface-staining for mPR3 after migration Finally, we investigated potential consequences of mPR3 expression in a more general setting-in the absence of ANCA. We tested the hypothesis that mPR3 high neutrophils would transmigrate faster through extracellular matrix toward an interleukin (Il)-8 gradient. Transwell plates were coated with fibronectin, an extracellular matrix that is easily degraded by PR3. mPR3 high and mPR3 low were separated and subjected to the upper well. Cells that had migrated into the IL-8-containing lower well were assayed. Under these conditions no difference was observed (Fig. 10) . To exclude that this result was influenced by the mab to PR3 that was used for cell sorting, and could still be bound to the neutrophil surface, we repeated these experiments using a different approach. Transmigration of unseparated neutrophils toward an IL-8 chemotactic gradient was monitored. We hypothesized that mPR3 high neutrophils would migrate faster through fibronectin, and therefore cells with the higher mPR3 expression would arrive at first in the lower well. Thus, we collected transmigrated cells at 30-minute intervals up to 120 minutes, and performed surface staining for membrane PR3. There was no migration advantage for mPR3 high neutrophils at any of the indicated time points (Fig. 10) . These data suggest that mPR3 phenotype is not the only determinant of neutrophil transmigration, and that additional proteolytic enzymes are at work, compensating for differences in mPR3 expression.
DISCUSSION
We explored the functional consequences of mPR3 high and mPR3 low neutrophil phenotypes in the setting of PR3-ANCA vasculitis. Our data are the first to show that PR3-ANCA-induced generation of reactive oxygen species and release of granule proteins are significantly higher in the mPR3 high neutrophil subset than in the mPR3 low subset. In addition, we found significant stronger activation of the PI3-K/Akt pathway in PR3-ANCA-stimulated mPR3 high neutrophils. Moreover, the mPR3 high and mPR3 low subsets differed neither in the ability to mobilize primary, specific, and secretory granules, nor in the expression of other molecules with putative implications in ANCA-induced neutrophil activation.
In WG, PR3 is the major autoantigen recognized by ANCA. This serine protease is stored intracellularly in azurophilic, specific, and secretory granules of neutrophils [14] [15] [16] 28] , but some PR3 can also be detected on the cell surface of resting cells [17, 19] . mPR3 expression is bimodal and an mPR3 high and mPR3 low subset can be distinguished [18, 19] .
ANCA can activate TNF-a-primed neutrophils, and activated neutrophils induce endothelial cell damage. Whether or not the mPR3 phenotype is of functional significance for the activation process is yet unknown; however, the PR3 phenotype could be one of the reasons for the clinical observation that WG patients with a larger percentage of mPR3 high neutrophils have higher relapse rates during the disease [21] . We tested the hypothesis that PR3-ANCA can more easily interact with mPR3 high neutrophils resulting in increased cell activation. Our data, obtained using physically separated mPR3 high and mPR3 low subsets of a given donor, demonstrate that PR3-ANCA indeed triggered a significantly stronger respiratory burst activity and degranulation in mPR3 high neutrophils compared with the mPR3 low counterparts of the same individual. Neutrophil responses show high donor variability. The advantage of our approach was to exclude this donor variability that may have influenced our results, had we merely compared different low and high mPR3 expressing donors. "Reintroducing" mPR3 high cells into mPR3 low samples of the same donor increased the ability of PR3-ANCA to trigger a higher degree of superoxide generation, demonstrating the dose-dependency of this effect. Finally, differences in the activation of the mPR3 high cells and mPR3 low subset occurred only when PR3-ANCA were used for stimulation, but not when other compounds, such as MPO-ANCA, control immunoglobulins, PMA, or fMLP were employed.
In search for mechanisms explaining our functional observations, we studied intracellular signaling events with respect to the mPR3 expression. We and others demonstrated recently that the PI3-K/Akt pathway is activated by ANCA, but not by control immunoglobulins, and that this pathway controls ANCA-induced respiratory burst [4, 5] . In agreement with these observations, we found in this study that activation of PI3-K/Akt was significantly stronger in PR3-ANCA-treated mPR3 high cells in comparison to their mPR3 low counterparts from the same individual. These data underscore the importance of the antibody antigen interaction for ANCA-induced neutrophil activation. Our findings may, at least in part, explain the differences in the clinical course in WG patients dependent on the mPR3 phenotype.
However, additional surface molecules were implicated in ANCA-induced neutrophil activation, including Fcc receptors and b2-integrins. Therefore, we studied the expression of these molecules with respect to the mPR3 phenotype. Both cross-linking of ANCA target antigens on the surface of neutrophils and engagement of Fcc receptors may play a role in the activation process [4, [8] [9] [10] [29] [30] [31] . We observed that expression of the Fcc receptors IIa and IIIb was similar on mPR3 high and mPR3 low neutrophils. In addition to Fcc-receptors, b2-integrins were implicated in ANCAmediated neutrophil activation. This class of integrins consists of a common b chain (CD18) that is noncovalently linked to three unique but related a-chains (CD11a, CD11b, CD11c). In fact, CD11b/CD18 were up-regulated in granulocytes of patients with active WG [32] , and ANCA-positive sera stimulated up-regulation of the same adhesion molecule in vitro [33] . Moreover, using blocking antibodies to CD18, Reumaux et al demonstrated that activation of the respiratory burst by ANCA was dependent on engagement of b2-integrins [10] . However, when we investigated membrane expression of CD11a, CD11b, CD11c, or CD18 with respect to the mPR3 high and mPR3 low subset, we found no differences. Low and high mPR3 expressing cells did also not differ in their ability to adhere to extracellular matrix proteins. These data indicate that differentially expressed mPR3 is not accompanied by differences in the expression of other surface molecules that are implicated in ANCA-mediated neutrophil activation. This finding holds true for constitutive expression, as well as for up-regulated expression during activation, and provides further support for the importance of ANCA-binding to the target antigens in the activation process because mPR3 expression was the only identifiable variable on both neutrophil subsets. We investigated a total of 12 membrane molecules, and we excluded bimodal expression also of other serine proteinases, such as elastase and cathepsin G and the second main ANCA target antigen, MPO. However, we cannot exclude additional yet unknown differences that may have influenced our findings and may play a role in neutrophil activation by ANCA.
We demonstrated recently that the intracellular content of PR3 was similar in mPR3 high and mPR3 low neutrophils [20] . Thus, conceivably low and high mPR3 expression may result from differences in the ability to mobilize intracellular granules. PR3 is found in azurophilic, specific, and secretory granules [14] [15] [16] . We used markers for all three of these granules and did not find differences in the translocation of azurophilic (CD63), specific (CD11a), or secretory (CD35) vesicles when comparing both mPR3 subsets. Further studies are needed to explore this issue. Potential explanations include modifications in the PR3 molecule itself resulting in more or less effective membrane insertion or differences in PR3 receptor status. In fact, a PR3 receptor was suggested in endothelial cells [34] , but evidence for its existence in neutrophils is still lacking.
Finally, we investigated potential consequences of the mPR3 phenotype in a more general biological setting in the absence of ANCA. We explored neutrophil migration through extracellular matrix toward a chemotactic gradient and speculated that mPR3 high neutrophils had a migration advantage in that they would more easily degrade matrix substance such as fibronectin. Cepinskas et al demonstrated that membrane-bound elastase plays a role in transmigration [35, 36] . MembranePR3 is a bioactive enzyme and is, in contrast to soluble PR3, resistant to physiologic proteinase inhibitors [22] . Using two different approaches, we did not find accelerated transmigration of mPR3 high neutrophils through a fibronectin matrix.
CONCLUSION
Our data demonstrate functional consequences of the mPR3 expression phenotype in human neutrophils in the presence of PR3-ANCA. This study may shed some light in the clinical observation that a larger percentage of mPR3 high subset is associated with both the occurrence and a higher relapse rate in WG patients.
